16 May 2022 marked the third instalment of Rooftop Pitch Potsdam. Around a dozen startup teams joined the event at the WIS building to present their business ideas to a selection of investors. There was a lot at stake: the latter were ready to fund good ideas and teams to the tune of up to €300,000 and wield their rolodexes on their behalf.
Unfortunately, nothing matched your filter. Please try again with different criteria.
Virtual Reality has been a buzzword for some time now. Vragments is one company that’s helping companies digitalize using innovative solutions such as VR. From their beginnings in immersive storytelling and projects like a virtual model of Berlin’s new BER airport, they’re now shifting towards advising clients on their Industry 4.0 transformation processes. CEO Professor Linda Rath tells us about their goals, the approach they’ve been taking, and why the Potsdam Science Park is the best place to be for what they’re doing.
Molecular diagnostics are dedicated to analysing genetic material. Just as DNA is highly complex in itself and must be isolated from other molecules, the methods and procedures in this field are highly complicated. Bremen-based company Molzym offers molecular diagnostics solutions for a wide range of pathogens that cause infectious diseases. At Potsdam Science Park, the company is conducting research to considerably speed up molecular diagnostics in the area of sepsis, also known as blood poisoning, to allow for improved targeted treatment.
One of the biggest business success stories at the Potsdam Science Park has been RIPAC-LABOR. After more than 18 years at the helm, successful founder and entrepreneur Dagmar Köhler-Repp has passed the mantle to Heiko Rüdiger, a veteran executive who has plans to give the company a stronger international presence, especially now that it’s part of Dopharma.
With over 25 years of experience supporting startups, 300 of them nurtured over the last 10 years alone, and ranked 3rd in Startup Radar 2021, Potsdam Transfer’s Start-up Service is one of Germany’s most successful. In this interview we hear from its head of, Johannes Zier, on how he and the team got to this position, the advice he gives to scientists looking to found start-ups, and why the Potsdam Science Park is so important for the start-up scene in Germany and beyond.
Artificial intelligence is one of the big trending topics of our time. But what exactly can it do? Biotx.ai, a company based in the Potsdam Science Park, manages to recognize complex patterns in genomic data with its AI platform, enabling it to make precise predictions about the efficacy of new therapies. Their approach could radically shorten the time needed for such studies, revolutionizing an entire industry. Biotx.ai COO Christian Hebenstreit explains how this works in our interview.
In a way, BIOCYC is one of the hidden champions of the Potsdam Science Park. Producing peptides for both the pharmaceutical industry and research as well as antibodies for cancer diagnostics, their success allows them to build their own production building in the Potsdam Science Park. In our interview, BIOCYC CEO Alexander Gorczyza talks about antibodies for cancer diagnostics and why the Potsdam Science Park is the ideal location for the growing company.
Osteoporosis effects billions of people worldwide and creates economic costs of about 60 billion US Dollars annually. Until recently, the early diagnosis of the disorder with conventional means has been nearly impossible. The MedTech startup Porous GmbH, a spin-off of Charité Berlin, is planning to change that. In our interview, CEO Bart Hendriks tells us how.
Starting in January 2022, new companies and research groups will move into the newly built H-LAB in the Potsdam Science Park. Among them will be QMEDIS Analytics, a contract lab where drugs are not only analysed but also produced. In our interview, Dr. Dennis Stracke explains how the lab works and how drug printers could revolutionise the industry.
Scientists around the world are researching ways for a better treatment of cancer. One of them is offered by GILUPI, a company founded in 2006. With their product, medical personnel can extract cancer cells from the blood. Dr. Christian Jurinke has been the company’s CEO since 2018. In our interview, he explains why good diagnostics are crucial for cancer therapy and why they have moved into their new office at GO:IN 2 in the Potsdam Science Park.
Research and business in the field of biology face the immense challenge of analysing and evaluating huge amounts of data. The company Eagle Genomics has set out to make this complexity manageable with the help of network science and artificial intelligence. In 2021, the company will open its first German location in the Potsdam Science Park. A conversation with Dr Sven Sewitz, Head of Biodata Innovation at Eagle Genomics.
Nicolas Hartmann and the vly team offer a milk derived from pea proteins. Thanks to a TV program, they became known throughout Germany. What few people know: In order to build up their start-up, they received valuable support from Potsdam Transfer at the University of Potsdam: their EXIST-Gründerstipendium. The story of a start-up with the ambition to make the world a better place.
For our interview series “Game Changers” we met deep technology entrepreneur Mike Richardson, who develops spectrographic sensors with his company Photonic Insights (www.photonicinsights.com) in the GO:IN Startup Space at the Potsdam Science Park. Find out what drives Richardson and what advice he shares with other founders.